Business Description
Sunshine Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8677811064
Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 24.76 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.65 | |||||
| Beneish M-Score | 2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 140.8 | |||||
| 3-Year EBITDA Growth Rate | 60.7 | |||||
| 3-Year EPS without NRI Growth Rate | 36.1 | |||||
| 3-Year FCF Growth Rate | 15.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.48 | |||||
| 9-Day RSI | 31.18 | |||||
| 14-Day RSI | 36 | |||||
| 6-1 Month Momentum % | -82.85 | |||||
| 12-1 Month Momentum % | -92.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.48 | |||||
| Quick Ratio | 3.45 | |||||
| Cash Ratio | 2.93 | |||||
| Days Inventory | 99.64 | |||||
| Days Sales Outstanding | 31.21 | |||||
| Days Payable | 56.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -152.9 | |||||
| Shareholder Yield % | -91.58 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.61 | |||||
| Operating Margin % | -19.86 | |||||
| Net Margin % | -18.7 | |||||
| FCF Margin % | -39.69 | |||||
| ROE % | -20.99 | |||||
| ROA % | -16.13 | |||||
| ROIC % | -147.16 | |||||
| ROC (Joel Greenblatt) % | -166.18 | |||||
| ROCE % | -17.98 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.04 | |||||
| PB Ratio | 0.04 | |||||
| Price-to-Tangible-Book | 0.05 | |||||
| EV-to-EBIT | 2.98 | |||||
| EV-to-EBITDA | 3.09 | |||||
| EV-to-Revenue | -0.49 | |||||
| EV-to-FCF | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 0.05 | |||||
| Price-to-Net-Cash | 0.09 | |||||
| Earnings Yield (Greenblatt) % | 33.56 | |||||
| FCF Yield % | -289.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SBFM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunshine Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 24.093 | ||
| EPS (TTM) ($) | -19.7 | ||
| Beta | 1.39 | ||
| Volatility % | 77.91 | ||
| 14-Day RSI | 36 | ||
| 14-Day ATR ($) | 2.074443 | ||
| 20-Day SMA ($) | 7.614 | ||
| 12-1 Month Momentum % | -92.13 | ||
| 52-Week Range ($) | 3.1 - 140 | ||
| Shares Outstanding (Mil) | 0.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunshine Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunshine Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunshine Biopharma Inc Frequently Asked Questions
What is Sunshine Biopharma Inc(SBFM)'s stock price today?
The current price of SBFM is $3.32. The 52 week high of SBFM is $140.00 and 52 week low is $3.10.
When is next earnings date of Sunshine Biopharma Inc(SBFM)?
The next earnings date of Sunshine Biopharma Inc(SBFM) is 2024-05-10 Est..
Does Sunshine Biopharma Inc(SBFM) pay dividends? If so, how much?
Sunshine Biopharma Inc(SBFM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers